Last week, the National Institute of Standards and Technology (NIST,) working through the Genome in a Bottle Consortium (GIABC) (a NIST-funded and initiated working group) pushed next generation sequencing (NGS) a little closer to being adopted into regular clinical practice. NIST/GIABC have released a standard for measuring the accuracy of genetic tests.Read More
Up at 5AM: The 5AM Solutions Blog
Physicians currently rely on a variety of techniques to diagnose disease, from imaging to physical examinations to laboratory tests. Personalized medicine, which allows targeted therapies to be confidently prescribed, i.e. getting the right medication to the right patient at the right time, relies on a diagnosis that takes into account the molecular characteristics of the patient and the disease.